As reported in the quarterly report they have funds to last another year.
I haven't heard of an instance when NNVC tried to raise money and failed.
"can they raise money before they go bankrupt"?
Another odd imaginary binary choice for a circumstance that isn't binary...especially now that the near positives (tox and clinical trials) have the potential to exponentially increase the value of NNVC. Other that a fairly constant negative stream of personal commentary directed against the Doc's and investors and (wink wink) at One Lab Nerd.
With the positive news just reported in the quarterly report, clearly raising funds will be easier not more difficult.
Dr Seymour knowing when to step down...the BOD having Dr Diwan act as interim until the new CEO is announced...Dr. Meyer finalizing the valuation on VZV...and the report from the CRO on the candidates...and NNVC ramping up production.
The new CEO will likely have previous experience bringing a drug to market on their CV...there is much to look forward to this year...NNVC closing its doors is not one of them IMO...no bankruptcy.
Market Data 
Markets 
